Heart valve stenosis in laser spotlights: insights into a complex disease

Petra Büttner1, Roberta Galli2, Anett Jannasch1

  • 1Faculty of Medicine, TU Dresden, Herzzentrum Dresden, Klinik für Herzchirurgie, Dresden, Germany.

Insights

Degenerative heart valve disease research is advanced by a new imaging technique. This method allows detailed, three-dimensional examination of heart valve tissue without extensive processing, offering new insights into disease mechanisms.

Area of Science:

  • Biomedical Engineering
  • Medical Imaging
  • Cardiovascular Research

Background:

  • Degenerative heart valve disease affects over 3% of adults aged 65+, with valve replacement surgery as the only current therapy.
  • The disease involves structural disorganization and cellular changes in heart valves, with unclear causes and no pharmacological treatments.
  • Current research methods often require extensive processing of excised valve tissue, limiting in-depth analysis.

Purpose of the Study:

  • To introduce a novel, minimally invasive imaging technique for characterizing degenerative heart valve disease.
  • To enable simultaneous, three-dimensional examination of heart valve constituents without extensive sample manipulation.
  • To provide deeper insights into the complex structure and composition of diseased heart valves.

Main Methods:

  • Integration of coherent anti-Stokes Raman scattering (CARS) microscopy.
  • Utilization of endogenous two-photon excited fluorescence (TPEF).
  • Application of second harmonic generation (SHG) imaging.

Main Results:

  • Simultaneous, three-dimensional imaging of cusp constituents was achieved.
  • The novel technique allows examination without extensive sample preparation.
  • Impressive insights into the complex structure of diseased heart valves were obtained.

Conclusions:

  • The combined imaging approach offers a powerful new tool for studying heart valve disease.
  • This technique facilitates a more comprehensive understanding of valve degeneration.
  • It holds potential for advancing research into new therapeutic strategies for heart valve conditions.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
501
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
580
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.7K
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
663
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
402
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
540